Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VERU INC. Director's Dealing 2007

Apr 11, 2007

34598_dirs_2007-04-11_88aa8d03-76a5-4865-9203-0c7b0e812a9b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FEMALE HEALTH CO (FHCO)
CIK: 0000863894
Period of Report: 2007-04-09

Reporting Person: DEARHOLT STEPHEN M (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2007-04-09 Common Stock, par value $.01 per share X 95495 $1.16 Acquired 1398608 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2007-04-09 Common Stock Purchase Warrant $1.16 F 104505 Disposed 2008-03-25 Common Stock (104505) Direct
2007-04-09 Common Stock Purchase Warrant $1.16 X 95495 Disposed 2008-03-25 Common Stock (95495) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock, par value $.01 per share 26500 Indirect
Common Stock, par value $.01 per share 69500 Indirect
Common Stock, par value $.01 per share 275820 Indirect
Common Stock, par value $.01 per share 418100 Indirect

Footnotes

F1: Pursuant to a cashless warrant exercise program, the reporting person surrendered to The Female Health Company ("FHC") the requisite number of warrants to pay the exercise price on the 200,000 warrants being exercised. The requisite number of warrants surrendered was calculated based upon the spread between the market value of FHC common stock on the effective date of exercise and the exercise price on the warrants. The reporting person surrendered that number of warrants having an aggregate spread amount equal to the aggregate exercise price of the 200,000 warrants being exercised. The total exercise price for the 200,000 warrants was $232,000 and the market price of FHC common stock on the date of exercise was $2.22 per share. Accordingly, the reporting person surrendered 104,505 warrants to pay the exercise price on the 200,000 warrants being exercised by the reporting person for shares of FHC common stock.

F2: Shares are held by the reporting person's self-directed IRA.

F3: Shares are held by a profit sharing plan, of which the reporting person is a beneficiary.

F4: Shares are held by a trust, of which the reporting person is a trustee.

F5: Shares are held by a trust, of which the reporting person is a trustee.